Multi-omics characterization of PRMT5-associated MYC and proliferative programs in Group 3 medulloblastoma
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background: Group 3 medulloblastoma (G3-MB) carries the worst prognosis, and validated therapeutic targets downstream of MYC remain limited. We investigated PRMT5-associated molecular and clinical features in G3-MB. Methods and Results: We integrated 763 bulk transcriptomes, approximately 25,000 single-nucleus RNA-seq profiles from 12 G3-MB patients, and 144 paired methylation-expression data. PRMT5 was higher in G3-MB than in SHH tumors and was independently associated with poor overall survival in an institutional validation cohort. Its expression was not associated with copy-number gain, but correlated with promoter hypomethylation and MYC/E2F1/SP1 co-expression. Network analysis placed PRMT5 in a MYC-correlated module enriched for ribosome biogenesis. At single-nucleus resolution, PRMT5-positive tumor cells showed elevated MYC and proliferation programs, although these associations were sensitive to detection threshold and library size. PRMT5-high tumors showed expression of genes linked to PRMT5-inhibitor pathways, DNA damage response, and replication stress. An exploratory seven-gene PRMT5-associated continuous score showed prognostic signal in the training and institutional validation cohorts. Conclusions: Integrated analyses associate PRMT5 with MYC-linked ribosome biogenesis and proliferative programs in G3-MB. PRMT5 is a candidate prognostic marker, and the PRMT5-MYC-ribosome association is a testable preclinical hypothesis; functional studies are needed to establish therapeutic relevance.
Source: Research Square
Authors: Dongyang Wang(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft), Zhaoyang Feng(Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Visualization, Writing – original draft), Yuyan Liang(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Visualization, Writing – original draft), Ziwei Wang(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft), Xuan Chen(Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft), Kaiwen Deng(Data curation, Project administration), Fei Liu(Data curation, Project administration), Yu Su(Investigation, Resources), Xi Cheng(Investigation, Resources), Xiangceng Liu, Qiao Yang, Zhiyang Chen, Junyuan Tian, Yu Liu, Hailong Liu(Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision), Wei Wang(Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision), Tao Jiang(Conceptualization, Funding acquisition, Methodology, Supervision)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G3255227005, G3586660527
OpenAlex ID: W7234950065
